Orr, Colin J
Streetman, Aspen E
Carruyo, Ivan A
Beck, Amy L
Queen, Katie
Sanders, Tierra
Heerman, William J
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK132513-03)
National Institute of Diabetes and Digestive and Kidney Diseases (5T32DK007061)
Article History
Received: 20 December 2025
Accepted: 1 April 2026
First Online: 14 April 2026
Declarations
:
: Dr. Queen has the following disclosures: Novo Nordisk (speakers bureau), Rhythm Pharmaceuticals (consulting, advisory board, speakers bureau), Vivus (speakers bureau).